NCT04390568View on ClinicalTrials.gov

A Trial in Healthy Chinese Volunteers to Test How Different Doses of BI 655130 Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

April 7, 2021

Study Completion Date

June 4, 2021

Conditions
Healthy
Interventions
DRUG

Spesolimap

Spesolimap

Trial Locations (1)

200040

Huashan Hospital, Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY